课题基金 / 基金详情

Optimizing triple negative breast cancer therapy based on immune cell morphology

Optimizing triple negative breast cancer therapy based on immune cell morphology
基于免疫细胞形态优化三阴性乳腺癌治疗
批准号:
468140
负责人:
Nielsen Torsten O
金额:
$4.37万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2022
资助国家:
加拿大
项目状态:
已结题
起止时间:
2022-02-01 至 2024-02-01

项目摘要

项目成果

Nielsen Torsten O的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Women diagnosed with triple negative breast cancer face an aggressive, life-threatening disease. Intense chemotherapy remains part of their standard care. However, new evidence suggests that at least some of these breast cancers are cured by surgery and r
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translating Epigenomics into Clinical Care for Synovial Sarcoma
  • 批准号:
    479075
  • 项目类别:
    Operating Grants
  • 资助金额:
    $69.11万
  • 财政年份:
    2023
  • 负责人:
    Nielsen Torsten O
  • 依托单位:
Translating Epigenomics into Clinical Care for Synovial Sarcoma
  • 批准号:
    473362
  • 项目类别:
    Operating Grants
  • 资助金额:
    $7.29万
  • 财政年份:
    2022
  • 负责人:
    Nielsen Torsten O
  • 依托单位:
CSF1 pathway inhibitors in tenosynovial giant cell tumors and leiomyosarcoma
  • 批准号:
    200438
  • 项目类别:
    Operating Grants
  • 资助金额:
    $21.12万
  • 财政年份:
    2010
  • 负责人:
    Nielsen Torsten O
  • 依托单位:
海外基金